Bookmarks
Comparative effects of different antidiabetic treatments on COVID-19 mortality and vascular outcomes
Safe People
Organisation name
London School of Hygiene and Tropical Medicine
Organisation sector
Academic Institute
Applicant name(s)
Anna Schultze - Chief Investigator - London School of Hygiene & Tropical Medicine ( LSHTM )Anna Schultze - Corresponding Applicant - London School of Hygiene & Tropical Medicine ( LSHTM )Owen Taylor - Collaborator - London School of Hygiene & Tropical Medicine ( LSHTM )Rohini Mathur - Collaborator - London School of Hygiene & Tropical Medicine ( LSHTM )Selina Kim - Collaborator - London School of Hygiene & Tropical Medicine ( LSHTM )
Safe Projects
Project ID
CPRD09
Lay summary
Type 2 Diabetes Mellitus (T2DM) is a common, chronic health condition in which a person’s glucose levels are too high. This can cause a range of complications, including damage to the eyes and kidneys, heart disease, stroke and heart attacks.
Technical summary
Type 2 Diabetes Mellitus (T2DM) affects approximately ~5% of individuals in the UK, and can cause both microvascular complications, such as retinopathy, kidney disease and neuropathy, as well as macrovascular complications, such as coronary heart disease, stroke, myocardial infarction and heart failure. More recently, individuals with T2DM have also been found to be at increased risk of COVID-19 mortality, a risk which is particularly marked for those with poorly controlled diabetes (HbA1c levels > 58 mmol/mol).
Latest approval date
26/05/2021
Safe Data
Dataset(s) name
ONS Death Registration Data
Patient Level Index of Multiple Deprivation
Practice Level Index of Multiple Deprivation
Safe Setting
Access type
Release